It was demonstrated that mycoplasmas, gram-negative bacteria, and certain gram-positive bacteria share a similar protein antigen with a molecular weight ranging from 42,000 to 48,000. Western blotting (immunoblotting) with an antibody specific to a 43-kDa membrane protein of Mycoplasma fermentans showed the existence of this protein antigen in all Mycoplasma spp. tested (14 species), Acholeplasma laidlawii (1 strain), and gram-negative bacteria (8 species) but only in Staphylococcus aureus of four gram-positive species tested. Neither Ureaplasma urealyticum nor mammalian cell cultures showed any cross-reactions with this antibody. These proteins were found in both cytoplasmic and membrane fractions of mycoplasma cells but were not exposed on the surface of mycoplasmal or bacterial cells.
In the course of studies on the characterization of membrane proteins of Mycoplasma hominis (8) , a specific antibody directed against a 45-kDa membrane protein, which is one of the major membrane-associated proteins of M. hominis, showed strong cross-reactions with membrane-associated proteins of about 42 to 48 kDa of some Mycoplasma species. The cross-reactivity of a specific antibody against a 43-kDa membrane protein of M. fermentans with some mycoplasmal and bacterial strains was investigated. The cross-reactive antigen (referred to as the 45,000-molecularweight [45K] protein), with an apparent molecular weight of 42,000 to 48,000, deprnding on the species, was found in all Mycoplasma spp. and gram-negative bacteria tested and in Staphylococcus aureus, which is a gram-positive bacterium. Although the function and localization of the 45K protein in these microorganisms have not been established, the results of Western blots (immunoblots) of mycoplasmas, bacteria, and mammalian cell cultures with the antibody specific to the 45K protein of M. fermentans are reported here.
The mycoplasmal and bacterial strains used are listed in Table 1 . Mycoplasma spp. and Acholesplasma laidlawii were grown in a glucose or arginine broth medium consisting of 2.1% (wt/vol) PPLO broth base (Difco), 10% (vol/vol) horse serum, 0.002% (wt/vol) phenol red, and either 0.25% (wt/vol) glucose (glucose broth) or 0.25% (wt/vol) arginine monohydrochloride (arginine broth). The final pHs of the glucose and arginine broths were adjusted to 7.7 and 7.1, respectively. Ureaplasma urealyticum was cultured in Shepard fluid medium U-9 modified to contain only 5% (vol/vol) horse serum (10) .
Bacterial strains were cultured in brain heart infusion broth (Difco) at 31°C for 10 h. Mycoplasmas grown in 1 liter of each growth medium at 37°C were centrifuged (16,000 x g for 40 min) when their pHs began to change. The cell pellets were suspended in 200 ml of phosphate-buffered saline (PBS; pH 7.2) and centrifuged at 16,000 x g for 40 min. The pellets were washed twice by centrifugation, resuspended in a minimal amount of PBS, sonicated at 20 kHz for 3 min, and stored frozen at -30°C until used. Frozen mycoplasma stocks were thawed and centrifuged at 100,000 x g for 60 min, the pellets (membrane fraction) (6) were suspended to 3.0 mg of protein per ml in PBS, and an equal volume of sampling buffer (2% sodium dodecyl sulfate [SDS], 5% 2-mercaptoethanol, 10% glycerol, 62.5 mM Tris [pH 6.8]) was added. The supernatant was concentrated by ultrafiltration with a Centrimex tube (KB D-31; Sanko Junyaku Co., Tokyo, Japan) and used as the cytoplasmic fraction. Samples were then heated at 100°C for 5 min. Samples of bacterial strains were prepared by centriguation at 3,000 x g for 10 min, washed with PBS, irradiated with a UV lamp for 120 min, and sonicated at 20 kHz for 3 min. Bacterial samples were then suspended in the sampling buffer and heated at 100°C for 5 min. SDS-polyacrylamide gel electrophoresis (PAGE) was then carried out by the method of Laemmli (5), with 10 and 5% acrylamide in the separating and stacking gels, respectively. Electrophoretic transfer of the separated components to nitrocellulose sheets (HAWP 324FO; Millipore) and subsequent immunological staining were performed by modifications of the method of Towbin et al. (11) , as previously described (7) .
The 45K proteins of M. hominis and M. fermentans were purified by SDS-PAGE. After the 45-kDa protein band was stained with Coomassie blue, it was cut out of the gels, homogenized in sampling buffer, and subjected again to SDS-PAGE. These procedures were repeated twice more. The 45-kDa protein band cut out of the gels was homogenized in PBS and injected intraperitoneally into BALB/c female mice (5 weeks old). The mice were given booster injections twice intraperitoneally with the same protein antigen at 2-week intervals. Two weeks after the third injection, the mice were bled, and the serum was used as monospecific antibodies (MsAb) against the 45K proteins of M. hominis (MsAb-H) and M. fermentans (MsAb-F). aureus, which is a gram-positive bacterium (Fig. 3) . Cultured cells such as Vero (African green monkey kidney), 3T6-Swiss albino (mouse embryo), WI-38 (human lung), and SP2/0 (mouse myeloma) and growth medium for mycoplasmas did not show any cross-reactions with MsAb-F (data not shown). Figure 4 shows the immunoblot of cytoplasmic and membrane fractions from M. pneumoniae, A. laidlawii, M. fermentans, and M. hominis with MsAb-F. The 45K protein was found in both cytoplasmic and membrane fractions of mycoplasma cells and seemed to be a major component of mycoplasmas, judging from Coomassie blue staining. Although immunofluorescence and immunoperoxidase staining procedures were performed on the colonies of several mycoplasma strains, Escherichia coli, and S. aureus with MsAb-F, the staining results were negative (data not shown). These results suggest that the 45K protein is not exposed on the surface of these microorganisms. There have been some reports of monoclonal antibodies (MAbs) which might recognize the epitopes of the 45K protein of mycoplasmas (1-3). Their blotting patterns for mycoplasmas also differed from species to species, and the relative positions of the 45K protein of each species on the immunoblot were consistent with the blotting results shown in Fig. 1 These results suggest that the 45K protein has various antigenic epitopes.
A considerable amount of the 45K protein was detected in both cytoplasmic and membrane fractions (Fig. 4) 
